Company overview
CIN
U80903PN1984PTC032945
Name
Serum Institute Of India Private Limited
Entity type
Private
Paid up capital
₹48,192,530
Authorized capital
₹550,000,000
Industry name
Community, personal and Social Services
Registry
ROC Pune
Status
Active
Incorporation date
22 May 1984
Address
212/2 Off Soli Poonawalla Road, Hadapsar, Pune, Pune, Maharashtra
Postal code
411028
Country
India
Primary goods traded
| Name | DIN | Designation | Join Date | Resign Date |
|---|---|---|---|---|
| Natasha Adar Poonawalla | 01264082 | 30 June 2016 | ||
| Behroze Zavareh Poonawalla | 00044877 | Director | 1 February 1986 | |
| Zavareh Soli Poonawalla | 00044760 | Director | 22 May 1984 | |
| Umesh Sharad Shaligram | 00212458 | Wholetime Director | 8 December 2020 | |
| Satish Damodar Ravetkar | 05175036 | Wholetime Director | 19 January 2012 | |
| Satish Ramchandra Mundra | 00416654 | Wholetime Director | 1 April 2010 | |
| Adar Cyrus Poonawalla | 00044815 | Wholetime Director | 1 April 2008 | |
| Subhash Vinayak Kapre | 00112145 | Wholetime Director | 12 October 1992 | 30 September 2011 |
| Rajeev Mhalasakant Dhere | 05174953 | Wholetime Director | 7 August 2012 | |
| Suresh Sakharam Jadhav | 00056701 | 1 April 2010 | ||
| Cyrus Soli Poonawalla | 00044650 | Managing Director | 1 July 2007 |
| Data Source | HS Code | Description | Buyer | Buyer Country | Seller | Seller Country | ||
|---|---|---|---|---|---|---|---|---|
| 22 March 2022 | IN | 84219900 | Mat Code: 5182507T0--Ga. Sartofluor Ga Cartridge.(po No. 5500000033) | Serum Institute Of India Private Limited | IN | Sartorius Stedim Biotech Gmbh | $57,656,900.00 | |
| 3 March 2022 | IN | 30024119 | Matrix-A Adjuvant Agc21 Mata-40 41 45 46 47 49 50 51 54 55 (Required For Novavax) (Transit Temp 2 To 8 Degree Celcius)(p | Serum Institute Of India Private Limited | IN | Novavax Inc | $28,386,900.00 | |
| 20 April 2022 | IN | 30024119 | Matrix-C Adjuvant (Required For Novavax) (Transit Temp 2 To 8 Degree Celcius) Item Code No. 10003322(P.O.No. 5100020928 | Serum Institute Of India Private Limited | IN | Novavax Inc | $18,396,361.10 | |
| 1 March 2022 | IN | 30024119 | Matrix-C Adjuvant Agc21 Matc-022 (Required For Novavax) (Transit Temp 2 To 8 Degree Celcius) Item Code No. 10003323(P.O. | Serum Institute Of India Private Limited | IN | Novavax Inc | $18,343,800.00 | |
| 4 April 2022 | IN | 30024119 | Matrix-C Adjuvant (Required For Novavax) (Transit Temp 2 To 8 Degree Celcius) Item Code No. 10003322(P.O.No. 5100020928 | Serum Institute Of India Private Limited | IN | Novavax Inc | $13,357,821.96 | |
| 3 March 2022 | IN | 30024119 | Matrix-A Adjuvant Agc21 Mata-027 28 30 (Required For Novavax) (Transit Temp 2 To 8 Degree Celcius) Item Code No. 1000332 | Serum Institute Of India Private Limited | IN | Novavax Inc | $8,697,030.00 | |
| 25 July 2022 | IN | 30024119 | Nvx-Cov2373 Drug Substance(foc Cons. No. 190/Ncg/2022-23) | Serum Institute Of India Private Limited | IN | Ups Netherland Sac Novavax United States | $7,445,248.58 | |
| 18 September 2022 | IN | 30024119 | Nvx-Cov2373 Drug Substance Batch No. As Per Document No. Sk-Ci-22091301 Dt. 13.09.2022.Foc Cons. No. 293/Ncg/2022-23 | Serum Institute Of India Private Limited | IN | Sk Bioscience Company Limited | $7,366,156.95 | |
| 22 July 2022 | IN | 30024119 | Nvx-Cov2373 Drug Substance(foc Cons. No. 186/Ncg/2022-23) | Serum Institute Of India Private Limited | IN | Ups Netherland Sac Novavax United States | $6,989,268.43 | |
| 22 July 2022 | IN | 30024119 | Nvx-Cov2373 Drug Substance(foc Cons. No. 185/Ncg/2022-23) | Serum Institute Of India Private Limited | IN | Ups Netherland Sac Novavax United States | $6,618,234.70 |
| Partner | Type | Total Value | Percentage |
|---|---|---|---|
| CV Bionest Asia | buyer | $40,496,089 | 7.46% |
| PT Bio Farma Disingkat PT. Bio Farma (Persero) | buyer | $24,962,876 | 4.60% |
| Pall Filtration Pte Ltd | seller | $6,467,318 | 1.19% |